Frontlight ResearchEarly access
Hypertrophic cardiomyopathy trials in Sweden
1 of 2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleShort and long-term Hemodynamic and Physiological Effects of Mavacamten in Obstructive Hypertrophic Cardiomyopathy
- Where
- Lund, Solna
- Age
- 18 years and over
- People
- 40
- Run by
- Region Skane
See details and how to join2025-524722-17-00